AAAAAA
Results:
1-19
|
Results: 19
Authors:
Perazella, MA
Citation: Ma. Perazella, COX-2 inhibitors and the kidney, HOSP PRACT, 36(3), 2001, pp. 43
Authors:
Perazella, MA
Citation: Ma. Perazella, Pharmacologic options available to treat symptomatic intradialytic hypotension, AM J KIDNEY, 38(4), 2001, pp. S26-S36
Authors:
Reilly, RF
Tray, K
Perazella, MA
Citation: Rf. Reilly et al., Indinavir nephropathy revisited: A pattern of insidious renal failure withidentifiable risk factors, AM J KIDNEY, 38(4), 2001, pp. E23-NIL_97
Authors:
Alappan, R
Cruz, D
Abu-Alfa, AK
Mahnensmith, R
Perazella, MA
Citation: R. Alappan et al., Treatment of severe intradialytic hypotension with the addition of high dialysate calcium concentration to midodrine and/or cool dialysate, AM J KIDNEY, 37(2), 2001, pp. 294-299
Authors:
Eras, J
Perazella, MA
Citation: J. Eras et Ma. Perazella, NSAIDs and the kidney revisited: Are selective cyclooxygenase-2 inhibitorssafe?, AM J MED SC, 321(3), 2001, pp. 181-190
Authors:
Perazella, MA
Tray, K
Citation: Ma. Perazella et K. Tray, Selective cyclooxygenase-2 inhibitors: A pattern of nephrotoxicity similarto traditional nonsteroidal anti-inflammatory drugs, AM J MED, 111(1), 2001, pp. 64-67
Authors:
Abu-Alfa, AK
Cruz, D
Perazella, MA
Mahnensmith, RL
Simon, D
Bia, MJ
Citation: Ak. Abu-alfa et al., ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients, AM J KIDNEY, 35(6), 2000, pp. 1076-1082
Authors:
Perazella, MA
Eras, J
Citation: Ma. Perazella et J. Eras, Are selective COX-2 inhibitors nephrotoxic?, AM J KIDNEY, 35(5), 2000, pp. 937-940
Authors:
Perazella, MA
Citation: Ma. Perazella, Trimethoprim-induced hyperkalaemia - Clinical data, mechanism, prevention and management, DRUG SAFETY, 22(3), 2000, pp. 227-236
Authors:
Perazella, MA
Citation: Ma. Perazella, Acute renal failure in HIV-infected patients: A brief review of common causes, AM J MED SC, 319(6), 2000, pp. 385-391
Authors:
Perazella, MA
Citation: Ma. Perazella, Drug-induced hyperkalemia: Old culprits and new offenders, AM J MED, 109(4), 2000, pp. 307-314
Authors:
Perazella, MA
Citation: Ma. Perazella, Approach to patients with intradialytic hypotension: A focus on therapeutic options, SEMIN DIAL, 12(3), 1999, pp. 175-181
Authors:
Cruz, DN
Mahnensmith, RL
Brickel, HM
Perazella, MA
Citation: Dn. Cruz et al., Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension, AM J KIDNEY, 33(5), 1999, pp. 920-926
Authors:
Perazella, MA
Biswas, P
Citation: Ma. Perazella et P. Biswas, Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapy, AM J KIDNEY, 33(4), 1999, pp. 782-785
Authors:
Perazella, MA
Cruz, DN
Citation: Ma. Perazella et Dn. Cruz, Ringer's lactate: An inexpensive and effective dialysate for continuous renal replacement therapy, AM J KIDNEY, 33(3), 1999, pp. 614-615
Authors:
Alappan, R
Buller, GK
Perazella, MA
Citation: R. Alappan et al., Trimethoprim-sulfamethoxazole therapy in outpatients: Is hyperkalemia a significant problem?, AM J NEPHR, 19(3), 1999, pp. 389-394
Authors:
Orias, M
Mahnensmith, RL
Perazella, MA
Citation: M. Orias et al., Extreme hyperphosphatemia and acute renal failure after a phosphorus-containing bowel regimen, AM J NEPHR, 19(1), 1999, pp. 60-63
Authors:
Perazella, MA
Citation: Ma. Perazella, Crystal-induced acute renal failure, AM J MED, 106(4), 1999, pp. 459-465
Authors:
Perazella, MA
MAhnensmith, RL
Citation: Ma. Perazella et Rl. Mahnensmith, Malignant hypertension, N ENG J MED, 339(27), 1998, pp. 1985-1985
Risultati:
1-19
|